Brilinta 90 MG tablet 60S
Ended Awarded Last action
- Contract number
- SPE2DR26FT5EG
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,738
Award facts
- Contract value 100% obligated
- $17,738.35 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, awarded on January 7, 2026, by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, covers the supply of BRILINTA 90 mg tablets (60-count units) with a firm fixed price ceiling value of $17,738.35 and completion date of January 8, 2026. The award represents a competitive, non-set-aside procurement issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive global pharmaceutical support vehicle running through December 2026. BRILINTA (ticagrelor) is an antiplatelet agent used in cardiovascular disease management, reflecting the types of critical medications the DLA Medical Supply Chain procures to support military healthcare operations and veteran services.
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, operates as a subsidiary of parent company Cencora, Inc., a major pharmaceutical distributor serving federal agencies. The delivery order exemplifies the company's established role as a primary vendor for federal pharmaceutical procurement, leveraging its broad portfolio and infrastructure to fulfill DLA's medical supply requirements. This single delivery order represents one of numerous task orders executed under the SPE2DX IDC, demonstrating the contractor's ongoing capacity to provide essential pharmaceutical commodities to military treatment facilities and federal healthcare systems worldwide.
Quick answers
Who was awarded contract SPE2DR26FT5EG?
SPE2DR26FT5EG was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 7, 2026.
How much is contract SPE2DR26FT5EG worth?
The government has obligated $17,738 on SPE2DR26FT5EG.
Is contract SPE2DR26FT5EG an order under another contract?
Yes. SPE2DR26FT5EG is a delivery order under SPE2DR25D3201, an indefinite delivery contract.
Was contract SPE2DR26FT5EG competed?
The extent of competition for SPE2DR26FT5EG was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award